Endothelial CXCR2 deficiency attenuates renal inflammation and glycocalyx shedding through NF-κB signaling in diabetic kidney disease

Siyuan Cui,Xin Chen,Jiayu Li,Wei Wang,Deqi Meng,Shenglong Zhu,Shiwei Shen
DOI: https://doi.org/10.1186/s12964-024-01565-2
IF: 7.525
2024-03-28
Cell Communication and Signaling
Abstract:The incidence of diabetic kidney disease (DKD) continues to rapidly increase, with limited available treatment options. One of the hallmarks of DKD is persistent inflammation, but the underlying molecular mechanisms of early diabetic kidney injury remain poorly understood. C-X-C chemokine receptor 2 (CXCR2), plays an important role in the progression of inflammation-related vascular diseases and may bridge between glomerular endothelium and persistent inflammation in DKD.
cell biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the molecular mechanisms of persistent inflammatory response and endothelial glycocalyx shedding in diabetic kidney disease (DKD). Specifically, the study focuses on the role of C - X - C chemokine receptor 2 (CXCR2) in early renal injury in DKD and its mechanism of regulating inflammation and glycocalyx dysfunction through the NF - κB signaling pathway. The study aims to evaluate the expression levels of CXCR2 and its ligands in DKD and explore their relationship with renal function. In addition, through a mouse model with endothelial - cell - specific knockout of Cxcr2 and glomerular endothelial cells (GECs) cultured under high - glucose conditions, the specific role and mechanism of CXCR2 in the progression of DKD are studied in detail. ### Main research questions: 1. **Expression and significance of CXCR2 in DKD**: - Study the expression levels of CXCR2 and its ligands in DKD patients. - Explore the relationship between CXCR2 expression and renal function indicators (such as urinary albumin - to - creatinine ratio UACR, serum creatinine Scr, etc.). 2. **Role of CXCR2 in inflammation and glycocalyx shedding**: - Through a mouse model with endothelial - cell - specific knockout of Cxcr2, study the effects of CXCR2 on renal function, inflammatory cell infiltration, and the expression of pro - inflammatory factors and chemokines. - Explore the regulatory role of CXCR2 in the inflammatory response and glycocalyx shedding of GECs under high - glucose conditions. 3. **Mechanism of CXCR2 through the NF - κB signaling pathway**: - Study how CXCR2 exacerbates the inflammatory response and glycocalyx dysfunction by activating the NF - κB signaling pathway. - Verify whether CXCR2 inhibitors can improve the symptoms of DKD, thereby providing a potential target for the treatment of DKD. ### Research methods: - **Clinical sample analysis**: Collect blood and kidney samples from healthy individuals and DKD patients to detect the expression levels of CXCR2 and its ligands. - **Animal experiments**: Use a mouse model with endothelial - cell - specific knockout of Cxcr2 to evaluate its role in DKD. - **Cell experiments**: Culture GECs under high - glucose conditions to study the expression and function of CXCR2. - **Molecular biology techniques**: Use immunohistochemistry, ELISA, qPCR, Western Blot and other techniques to detect the expression of related molecules and the activation of signaling pathways. ### Conclusions: - **CXCR2 is up - regulated in DKD**: CXCR2 is significantly up - regulated in the renal tissues of DKD patients and is related to the decline in renal function. - **CXCR2 knockout improves DKD symptoms**: The mouse model with endothelial - cell - specific knockout of Cxcr2 shows that CXCR2 knockout can significantly improve renal function, reduce inflammatory cell infiltration, and decrease the expression of pro - inflammatory factors and chemokines. - **CXCR2 regulates inflammation and glycocalyx function through the NF - κB signaling pathway**: CXCR2 exacerbates the inflammatory response and glycocalyx shedding by activating the NF - κB signaling pathway, and inhibiting CXCR2 can restore the endothelial glycocalyx and alleviate the symptoms of DKD. In summary, this study reveals the important role of CXCR2 in DKD and provides a theoretical basis for it as a potential treatment target.